CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Orphanetics Pharma Entwicklungs GmbH

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 7, 2007

Defunct as of Mar 16, 2007

Timeline

2000s

Jun 1, 2005
Orphanetics Pharma Entwicklungs GmbH— Founded
Mar 16, 2007
Orphanetics Pharma Entwicklungs GmbH— Defunct

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

sapropterin

Indications

Studied for

Phenylketonurias

Recent trials (1)

NCT00432822Lead sponsorPhase 2/Phase 3Feb 7, 2007

Details

Founded: Innsbruck, AT Jun 1, 2005
Last known activity: Feb 7, 2007